The proteasome inhibitor bortezomib acts differently in combination with p53 gene transfer or cytotoxic chemotherapy on NSCLC cells
Neukirchen, J, Meier, A, Rohrbeck, A, Garcia-Pardillos, G, Steidl, U, Fenk, R, Haas, R, Kronenwett, R, Rohr, U-PVolume:
14
Year:
2007
Language:
english
Pages:
9
DOI:
10.1038/sj.cgt.7701029
File:
PDF, 209 KB
english, 2007